HEALTHMEDPAGE TODAY
How a Drug With More Negative Than Positive Studies Won FDA Approval
A drug with more negative than positive studies received FDA approval, prompting calls for the FDA to include negative studies in product labeling to avoid misleading physicians and consumers about the drug's efficacy.
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
- STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
- STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval
- Doctors Are Worried About AI. They Use It Anyway.
- How an experimental weight-loss drug is being openly promoted by physicians